To Waive Or Not To Waive? Panel Presses For Simpler Blood Cell Counters
This article was originally published in The Gray Sheet
Executive Summary
The potential for less-sophisticated clinical laboratories to adopt automated blood cell counters remains uncertain after FDA's Hematology and Pathology Devices Panel suggested that simpler versions of the devices likely would be required